Tesla shares fall as CEO Elon Musk says he plans to form a new political party after reigniting a feud with President Donald ...

WNS (WNS) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the ...

Stock futures edged lower Monday morning as President Trump threatened an additional 10% tariff on countries supporting the ...

Bengaluru: India's French connection is growing stronger. French IT services firm Capgemini, which has more than half of its ...

S&P 500 E-Mini futures (ESU25) are up +0.08%, and September Nasdaq 100 E-Mini futures (NQU25) are up +0.17% this morning as ...

Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of WNS (Holdings) Limited (NYSE: WNS) to Capgemini for $76.50 per share is fair to WNS shareholders.

The U.S. Food and Drug Administration (FDA) on Monday approved KalVista Pharmaceuticals' Ekterly (sebetralstat) for acute attacks of hereditary angioedema (HAE) in adult and pediatric patients aged 12 ...

The transaction, which offers $76.50 per WNS share, reflects a 17% premium over WNS' most recent closing price and has received unanimous approval from both companies' boards. Capgemini expects the ...

Capgemini's shares fell over 5% following its $3.3 billion acquisition of BPO firm WNS, amid investor worries about the impact of AI on the BPO sector.